imatinib mesylate has been researched along with Seminoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, S; Katayama, Y; Matsui, T; Okamura, A; Wakahashi, K; Yamamoto, K | 1 |
| Graiff, C; Mazzoleni, G; Pedersini, R; Vattemi, E | 1 |
2 other study(ies) available for imatinib mesylate and Seminoma
| Article | Year |
|---|---|
Possible alternative strategy for stage I imatinib-sensitive testicular seminoma; lessons from a case associated with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Benzamides; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Male; Middle Aged; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Seminoma; Testicular Neoplasms | 2010 |
Complete response after treatment with imatinib in pretreated disseminated testicular seminoma with overexpression of c-KIT.
Topics: Adult; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Lung Neoplasms; Male; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Seminoma; Testicular Neoplasms; Tomography, Spiral Computed; Treatment Outcome; Up-Regulation | 2007 |